Latest return on equity
InMed Pharmaceuticals Return on equity
Direct answer
InMed Pharmaceuticals's return on equity is -112.65%.
The verified market snapshot reports -112.65%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 6, 2026.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -112.65%
Explore related company data
View InMed Pharmaceuticals's market capitalizationView InMed Pharmaceuticals's price-to-book ratioView InMed Pharmaceuticals's 52-week price rangeView InMed Pharmaceuticals's profit marginView InMed Pharmaceuticals's debt-to-equity ratioView all InMed Pharmaceuticals key metricsReturn to InMed Pharmaceuticals profile